Skip to main content

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study.

Author
Abstract
:

We examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM).

Year of Publication
:
2018
Journal
:
Journal of the American Heart Association
Volume
:
7
Issue
:
3
Date Published
:
2018
URL
:
http://jaha.ahajournals.org/cgi/pmidlookup?view=long&pmid=29367417
DOI
:
10.1161/JAHA.117.007393
Short Title
:
J Am Heart Assoc
Download citation